BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4574129)

  • 1. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
    Schönebeck J; Anséhn S
    Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of urinary candidosis with the oral antifungal drugs 5-fluorocytosine and 'clotrimazole'.
    Holt RJ; Newman RL
    Dev Med Child Neurol Suppl; 1972; 27():70-9. PubMed ID: 4566706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fungal urinary infection: report no. 1].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Hinyokika Kiyo; 1986 Oct; 32(10):1543-6. PubMed ID: 3565191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine.
    Speller DC
    J Clin Pathol; 1974 Jan; 27(1):50-2. PubMed ID: 4856590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).
    Marks MI; Steer P; Eickhoff TC
    Appl Microbiol; 1971 Jul; 22(1):93-5. PubMed ID: 5165106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C. albicans resistance to 5-fluorocytosine.
    Logan RL; Goldberg MJ
    Br Med J; 1972 Aug; 3(5825):531. PubMed ID: 4560727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity and resistance of Candida to 5-fluorocytosine, 5-fluorouracil and 5-fluorouridine. Relation to the ecology and serotype of C. albicans].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    C R Acad Hebd Seances Acad Sci D; 1974 Jan; 278(5):605-8. PubMed ID: 4211641
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 10. Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
    Osawa K; Shigemura K; Yoshida H; Fujisawa M; Arakawa S
    J Antibiot (Tokyo); 2013 Nov; 66(11):651-4. PubMed ID: 23801184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of flucytosine in patients with urinary fungal infections].
    Tokunaga S; Ohkawa M; Nakashima T; Yamaguchi K; Nishikawa T; Matsushita T; Mikawa I; Hirano S; Kawaguchi S; Miyagi T
    Jpn J Antibiot; 1992 Aug; 45(8):1060-4. PubMed ID: 1433895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U; Siddiqui MT; Faryal R; Shah AA
    J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
    Kostiala AA; Kostiala I
    J Med Microbiol; 1984 Oct; 18(2):249-54. PubMed ID: 6387127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
    Araj GF; Daher NK; Tabbarah ZA
    Int J Antimicrob Agents; 1998 Nov; 10(4):291-6. PubMed ID: 9916903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fungal infections with flucytosine.
    Harder EJ; Hermans PE
    Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypes of resistance to fluorophyrimidines and the occurence of 5-fluorocytosine resistant mutants in Candida and Torulopsis yeasts.
    Pawlik B; Barylak J
    Mykosen; 1978 Nov; 21(11):377-81. PubMed ID: 570245
    [No Abstract]   [Full Text] [Related]  

  • 20. Fungemia caused by torulopsis glabrata.
    Pankey GA; Daloviso JR
    Medicine (Baltimore); 1973 Sep; 52(5):395-403. PubMed ID: 4579980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.